SLI
|
2 325,30
|
-4,68
|
-0,20 %
|
Analysen zu SLI-Werten
| 23.10.26 | Novartis Sector Perform | RBC Capital Markets | |
| 23.10.26 | Nestlé Neutral | UBS AG | |
| 23.10.26 | Zurich Insurance Neutral | UBS AG | |
| 23.10.26 | Roche Outperform | RBC Capital Markets | |
| 23.10.26 | Nestlé Kaufen | DZ BANK | |
| 23.10.26 | Nestlé Hold | Deutsche Bank AG | |
| 23.10.26 | Roche Buy | UBS AG | |
| 23.10.26 | Nestlé Market-Perform | Bernstein Research | |
| 23.10.26 | Roche Underperform | Jefferies & Company Inc. | |
| 23.10.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 23.10.26 | Roche Buy | Deutsche Bank AG | |
| 23.10.26 | Swiss Re Underweight | Barclays Capital | |
| 22.10.26 | Roche Outperform | RBC Capital Markets | |
| 22.10.26 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 22.10.26 | Nestlé Buy | Jefferies & Company Inc. | |
| 22.10.26 | Nestlé Sector Perform | RBC Capital Markets | |
| 22.10.26 | Nestlé Market-Perform | Bernstein Research | |
| 22.10.26 | Nestlé Neutral | UBS AG | |
| 22.10.26 | ABB Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.10.26 | ABB Kaufen | DZ BANK | |
| 21.10.26 | ABB Market-Perform | Bernstein Research | |
| 21.10.26 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.10.26 | Richemont Outperform | RBC Capital Markets | |
| 21.10.26 | ABB Hold | Deutsche Bank AG | |
| 20.10.26 | Novartis Neutral | UBS AG | |
| 20.10.26 | ABB Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.10.26 | ABB Market-Perform | Bernstein Research | |
| 20.10.26 | Givaudan Underperform | Bernstein Research | |
| 20.10.26 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.10.26 | Swiss Re Underperform | RBC Capital Markets | |
| 16.10.26 | Givaudan Halten | DZ BANK | |
| 16.10.26 | Givaudan Neutral | UBS AG | |
| 16.10.26 | Novartis Sector Perform | RBC Capital Markets | |
| 16.10.26 | Givaudan Underperform | Bernstein Research | |
| 16.10.26 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 15.10.26 | Swiss Re Underweight | JP Morgan Chase & Co. | |
| 15.10.26 | Novartis Neutral | UBS AG | |
| 15.10.26 | Richemont Buy | Jefferies & Company Inc. | |
| 15.10.26 | Richemont Outperform | RBC Capital Markets | |
| 15.10.26 | Swiss Re Underperform | Jefferies & Company Inc. |